August 2009 - Neorphys has relocated to a new facility with extended space... Neorphys' Press Releases -....
About Neorphys
Founded in September 2005 by Dr Roger LAHANA, CEO, and Karine LARBOURET, Director of Operations, Neorphys is a company which discovers and develops novel, proprietary analgesic drug candidates with low side effects, especially with regard to gastro-intestinal transit. This is why the most advanced drug candidate is developed for visceral pain management.
Beside the co-founders, Neorphys scientists, all PhD’s or equivalent, share a strong expertise in opioids and acute pain as well as in behavioural pharmacology. They have a proven track record of success in using discovery techniques such as medicinal chemistry, cell biology, toxicology and relevant animal assays... About Neorphys -
